Patient Characteristics
| Variable | Data |
|---|---|
| Age at biopsy (y) | 64 (59–70) |
| Latest prostate-specific antigen result* (ng/mL) | 5.6 (4.2–7.5) |
| Clinical T-stage | |
| TX | 18 (6.2) |
| T1c | 197 (68) |
| T2a | 60 (21) |
| T2b | 14 (4.8) |
| T2c | 2 (0.7) |
| PI-RADS (mpMRI) | |
| 2 | 95 (33) |
| 3 | 53 (18) |
| 4 | 90 (31) |
| 5 | 53 (18) |
| Grade group (biopsy) | |
| No cancer | 77 (26) |
| 1 | 52 (18) |
| 2 | 102 (35) |
| 3 | 39 (13) |
| 4 | 7 (2.4) |
| 5 | 14 (4.8) |
| PSMA pattern† | |
| No pattern | 47 (16) |
| Diffuse TZ/CZ | 97 (33) |
| Focal TZ | 53 (18) |
| Focal PZ | 155 (53) |
* Prostate-specific antigen data missing for one patient.
↵†Number exceeds sample size because patient may exhibit more than one pattern simultaneously.
Qualitative data are number and percentage; continuous data are median and interquartile range.